📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OncoMethylome

1.1 - Company Overview

OncoMethylome Logo

OncoMethylome

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular diagnostics focused on developing gene methylation tests for early detection of cancer and personalized treatment decisions, offering novel, accurate, and informative diagnostic tools for treating physicians.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OncoMethylome

Resolution Bioscience Logo

Resolution Bioscience

HQ: United States Website
  • Description: Provider of next-generation liquid biopsy cancer diagnostics using NGS to interrogate cell-free DNA from blood. Offerings include the ctDx Platform; ctDx FIRST, an FDA-approved NGS assay for comprehensive genomic profiling of 109 genes and detection of KRAS G12C in NSCLC; ctDx Lung for real-time NSCLC genotype assessment; custom liquid-biopsy panels for clinical trials and companion diagnostics; and TCR profiling for immuno-oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Resolution Bioscience company profile →
BioTeam Logo

BioTeam

HQ: United States Website
  • Description: Provider of technology-based consulting services for organizations and enterprises.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioTeam company profile →
Molecular Assemblies Logo

Molecular Assemblies

HQ: United States Website
  • Description: Provider of proprietary Fully Enzymatic Synthesis (FES) technology to produce long, pure, accurate DNA up to 400 nucleotides without post-synthesis purification; custom DNA oligos for CRISPR, cloning and NGS; gene editing, protein engineering and gene assembly services; and a partnering program licensing FES for on-site synthesis with an automated platform, proprietary reagents and research-use licenses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Molecular Assemblies company profile →
Exiqon Logo

Exiqon

HQ: Denmark Website
  • Description: Provider of Life Sciences and Diagnostics solutions, offering flexible RNA analysis research products used by academia, biotech and pharmaceutical companies worldwide to investigate gene activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exiqon company profile →
Forma Therapeutics Logo

Forma Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery, development and commercialization of transformative medicines leveraging biology and chemistry to address genomically validated cancer drivers; haemophilia A prophylaxis with Mim8 and the FRONTIER clinical programme; diabetes care for children; low-cost insulin access; humanitarian health partnerships; and haemophilia care support via a dedicated foundation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forma Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OncoMethylome

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OncoMethylome

2.2 - Growth funds investing in similar companies to OncoMethylome

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OncoMethylome

4.2 - Public trading comparable groups for OncoMethylome

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OncoMethylome

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OncoMethylome

What does OncoMethylome do?

OncoMethylome is a provider of molecular diagnostics focused on developing gene methylation tests for early detection of cancer and personalized treatment decisions, offering novel, accurate, and informative diagnostic tools for treating physicians.

Who are OncoMethylome's competitors?

OncoMethylome's competitors and similar companies include Resolution Bioscience, BioTeam, Molecular Assemblies, Exiqon, and Forma Therapeutics.

Where is OncoMethylome headquartered?

OncoMethylome is headquartered in Belgium.

How many employees does OncoMethylome have?

OncoMethylome has 1,000 employees 🔒.

When was OncoMethylome founded?

OncoMethylome was founded in 2010 🔒.

What sector and industry vertical is OncoMethylome in?

OncoMethylome is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OncoMethylome

Who are the top strategic acquirers in OncoMethylome's sector and industry

Top strategic M&A buyers and acquirers in OncoMethylome's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OncoMethylome?

Top strategic M&A buyers groups and sectors for OncoMethylome include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OncoMethylome's sector and industry vertical

Which are the top PE firms investing in OncoMethylome's sector and industry vertical?

Top PE firms investing in OncoMethylome's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OncoMethylome's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OncoMethylome's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OncoMethylome's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OncoMethylome include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OncoMethylome's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OncoMethylome?

The key public trading comparables and valuation benchmarks for OncoMethylome include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OncoMethylome for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OncoMethylome with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OncoMethylome's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OncoMethylome with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OncoMethylome's' sector and industry vertical?

Access recent funding rounds and capital raises in OncoMethylome's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OncoMethylome